rdf:type |
|
lifeskim:mentions |
umls-concept:C0017337,
umls-concept:C0018810,
umls-concept:C0023976,
umls-concept:C0026882,
umls-concept:C0030705,
umls-concept:C0087111,
umls-concept:C0332206,
umls-concept:C0439799,
umls-concept:C0442805,
umls-concept:C0443199,
umls-concept:C0597484,
umls-concept:C0871261,
umls-concept:C1416572,
umls-concept:C1419864,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
pubmed:issue |
12
|
pubmed:dateCreated |
1996-1-23
|
pubmed:abstractText |
The genes for the long QT syndrome (LQTS) linked to chromosomes 3 (LQT3) and 7 (LQT2) were identified as SCN5A, the cardiac Na+ channel gene, and as HERG, a K+ channel gene. These findings opened the possibility of attempting gene-specific control of ventricular repolarization. We tested the hypothesis that the QT interval would shorten more in LQT3 than in LQT2 patients in response to mexiletine and also in response to increases in heart rate.
|
pubmed:grant |
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0009-7322
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
92
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3381-6
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:8521555-Adult,
pubmed-meshheading:8521555-Anti-Arrhythmia Agents,
pubmed-meshheading:8521555-Cardiac Pacing, Artificial,
pubmed-meshheading:8521555-Case-Control Studies,
pubmed-meshheading:8521555-Chromosome Mapping,
pubmed-meshheading:8521555-Chromosomes, Human, Pair 3,
pubmed-meshheading:8521555-Chromosomes, Human, Pair 7,
pubmed-meshheading:8521555-Female,
pubmed-meshheading:8521555-Heart Rate,
pubmed-meshheading:8521555-Humans,
pubmed-meshheading:8521555-Long QT Syndrome,
pubmed-meshheading:8521555-Male,
pubmed-meshheading:8521555-Mexiletine,
pubmed-meshheading:8521555-Mutation,
pubmed-meshheading:8521555-Potassium Channels,
pubmed-meshheading:8521555-Sodium Channel Blockers,
pubmed-meshheading:8521555-Sodium Channels
|
pubmed:year |
1995
|
pubmed:articleTitle |
Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy.
|
pubmed:affiliation |
Cattedra di Cardiologia, Università degli Studi di Pavia, Italy.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|